← Back to Directory

Curanex Pharmaceuticals Inc (CURX) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Curanex Pharmaceuticals Inc (CURX).

Download StockRank on Google Play Download StockRank on the App Store

Equity Details

Price & Market Data

Price: $0.339

Daily Change: +$0.0087 / 2.57%

Daily Range: $0.32 - $0.339

Market Cap: $9,278,782

Daily Volume: 44,362

Performance Metrics

1 Week: -9.81%

1 Month: -31.46%

3 Months: 8.92%

6 Months: -47.19%

1 Year: -91.38%

YTD: -0.97%

About Curanex Pharmaceuticals Inc (CURX)

Get a comprehensive snapshot of Curanex Pharmaceuticals Inc (CURX). Current price: 0.339, daily change: +$0.0087 / 2.57%. Market cap: 9,278,782. Performance YTD, 1-week, and 3-month.

Details

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.

Selected stocks

Expro Group Holdings N.V. (XPRO)

Generate Biomedicines, Inc. (GENB)

Versamet Royalties Corporation (VMET)

Blackrock Enhanced International Dividend Trust (BGY)

IRIDEX Corporation (IRIX)